Inhibikase Therapeutics, Inc. (IKT) › EPS (Basic)Inhibikase Therapeutics, Inc. (IKT) — EPS (Basic)Annual figures by period end, from SEC filings.2021-12-31: $-0.812022-12-31: $-4.282023-12-31: $-3.162024-12-31: $-1.162025-12-31: $-0.49$-0.492021-12-31EPS (Basic) (USD/shares)2025-12-31Period endedEPS (Basic)Change YoYSource filing2025-12-31$-0.49—2026-03-26From 2025-01-012024-12-31$-1.16—2026-03-26From 2024-01-012023-12-31$-3.16—2025-03-27From 2023-01-012022-12-31$-4.28—2024-03-27From 2022-01-012021-12-31$-0.81—2023-03-31From 2021-01-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted Shares